This news is important but it doesn't mean much to outsiders who have no idea about the company or the science behind Prolanta. Lots of OTC biotechs have drugs in phase I trials. Until they research the science they aren't going to care a whole lot. We need data from the trials. But it's reassuring to know that the process is underway and trial results are right around the corner.
News 
Market Data 
Discover 
AI
